Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulax vs Botox for Crow's Feet Lines
NCT03408236Phase 3Completed
- Sponsor
- Hugel
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A, sponsored by Hugel. Started Jan 2018; status: completed.
02
Drugs
botulinum toxin type A
Beyond the preview
Go deeper on NCT03408236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03408236.